Allan J Tobin

Graduating class of 1960



An accomplished student at Central, Allan was the Class Valedictorian, President of the Student Council, a member of the National Honor Society, on the staff of the Oracle, the Debate Society, the Radio Club, The National Forensic League—and he also was in the St. Paul’s Advanced Study Program for two summers. Allan went on to receive a B.S. in Humanities and Science in 1963 from M.I.T. then to Harvard University where he completed his Ph.D. in Biophysics in 1969. He spent a year as a Visiting Research Fellow at the Weizmann Institute of Science in Israel, and a second year as a Research Fellow in Biology at M.I.T. He had a faculty appointment at Harvard for six years, and then accepted a dual appointment at UCLA as a professor and a member of the Molecular Biology Institute. Dr. Tobin now holds the Eleanor Leslie Chair in Neuroscience at UCLA and is the Director of the UCLA Brain Research Institute. He is also the Scientific Director of the Hereditary Disease Foundation; an organization dedicated to finding the cause and cure of Huntington’s disease. He has had an active research laboratory for almost 30 years, first at Harvard and, since 1975, at UCLA. His research studies, it is hoped, may eventually lead to new therapeutic approaches to Epilepsy, Parkinson’s Disease and Juvenile Diabetes. Among numerous awards and honors, Dr. Tobin is the recipient of a Jacob Javitz Neuroscience Investigator Award from the National Institute of Neurological Disorders and Stroke. He is the coauthor of a text Asking About Life, which won the 1998 Award of Excellence from the Textbook and Academic Authors Association. In addition to a second book, his publications are voluminous and include over 100 chapters, reviews and research articles. A brilliant leader of many multidisciplinary workshops that have changed the course of neurological research and education, Allan has been a leading advocate—both at UCLA and nationally—for translational neuroscience, the movement of basic neuroscience advances into medical and technological applications.